Geno J Germano
CIK 1424383 · President · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$10.35M
Companies
12
Total Filings
96
Lifetime Open-Market Net
-$1.07M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DTIL | Director | 44,883 | $6.10 | $273.8K | $47.6K | 12 | 2026-06-05 |
| HRMY | Director | — | $34.46 | — | $0 | 1 | 2026-05-18 |
| ENTX | Director | 40,000 | $1.23 | $49.2K | $55.8K | 2 | 2026-03-11 |
| Sage Therapeutics, Inc. (SAGE) Delisted | Director | — | $8.68 | — | $0 | 12 | 2025-07-31 |
| MEDICINES CO /DE (MDCO) Delisted | Director | 0 | — | — | $0 | 4 | 2020-01-06 |
| Bioverativ Inc. (BIVV) Delisted | Director | — | — | — | $0 | 3 | 2018-03-08 |
| PRECIGEN, INC. (XON) Delisted | President | — | — | — | $0 | 3 | 2016-09-26 |
| PFE | Group President | 367,537 | $26.21 | $9.63M | -$1.12M | 49 | 2015-02-27 |
| PFIZER INC (PFE.WD) Delisted | Business Unit President | 227,457 | — | — | $0 | 2 | 2013-06-28 |
| ZTS | Director | 5,000 | $79.57 | $397.8K | $130.0K | 1 | 2013-02-08 |
| WYETH (WYEp.CL) Delisted | Pres.-US Pharm. & Wom. Health. | 44,893 | — | — | $0 | 1 | 2009-04-29 |
| WYETH (WYEp) Delisted | Pres.-US Pharm. & Wom. Health. | 46,357 | — | — | -$179.4K | 5 | 2009-03-03 |
Recent Filings · Page 2 of 10
96 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-02 | DTIL | Buy (P) | +3,605 | $16.2K | EDGAR |
| 2024-06-11 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-06 | DTIL | Grant (A) | — | $0 | EDGAR |
| 2024-05-07 | DTIL | Exer (M) | +4,202 | $0 | EDGAR |
| 2023-06-16 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-08 | DTIL | Grant (A) | — | $0 | EDGAR |
| 2022-06-17 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-12 | DTIL | Grant (A) | — | $0 | EDGAR |
| 2021-06-11 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-12 | DTIL | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.